Delivery Order SPE2DE21D0017-SPE2D626F22V7
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $3,600.00 for COVID-19 test kits on December 8, 2025, with an ultimate completion date of December 17, 2025. The contract utilizes a fixed-price structure with economic price adjustment and was issued without a set-aside designation. Performance will take place in Lake Mary, Florida. This delivery order is funded through the Defense Logistics Agency's Medical Supply Chain, a...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order valued at $3,600.00 for COVID-19 viral test kits containing 24 tests. The contract, issued on November 14, 2025, with an ultimate completion date of November 25, 2025, utilizes a fixed-price structure with economic price adjustment provisions. The award was made without a set-aside designation on a full and open competitive basis by the Defense Logistics Agency Medical Supply Chain, a...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a $2,400 delivery order for COVID-19 virus test kits containing 24 tests. Issued on December 16, 2025, with an ultimate completion date of December 26, 2025, this fixed-price delivery order with economic price adjustment was funded by the Defense Logistics Agency Medical Supply Chain without a set-aside designation. Performance will occur at the vendor's Lake Mary, Florida facility. This award...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $6,000.00 on December 16, 2025, for COVID-19 viral test kits (Kit ID NOW COVID-19 VIR TST 24 TST). This fixed-price contract with economic price adjustment features a performance location in Lake Mary, Florida, with an ultimate completion date of December 26, 2025. The award was issued without set-aside designation on a full and open competitive basis by the Defense Logistics...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $3,600 fixed-price delivery order with economic price adjustment on October 28, 2025, for COVID-19 virus test kits (Kit ID NOW COVID-19 VIR TST 24 TST). The contract is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by November 6, 2025, with performance based in Lockhart, Florida. This delivery order was awarded on a full and open basis without set-aside...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $4,800.00 on August 20, 2025, for COVID-19 test kits under contract 4569160719. This fixed-price contract with economic price adjustment has an ultimate completion date of August 29, 2025, and will be performed in Lockhart, Florida. The award was issued by the Defense Logistics Agency Medical Supply Chain without a set-aside designation, indicating open competition among...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on September 5, 2025, for COVID-19 test kits valued at $15,000.00 with a completion date of September 16, 2025. This fixed-price contract with economic price adjustment clauses was awarded without set-aside designation, indicating open competition. The Defense Logistics Agency Medical Supply Chain funded this award, and performance will be completed in Lockhart, Florida. The delivery order...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on April 28, 2025, for COVID-19 test kits with a ceiling value of $2,400.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of May 7, 2025, and will be performed in Lockhart, Florida. The contract was awarded without a set-aside designation, indicating open competition. The Defense Logistics Agency Medical Supply Chain, operating under...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $12,720.00 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency (DLA) Medical Supply Chain on October 15, 2025, with an ultimate completion date of October 21, 2025. The contract, which carries no set-aside designation and indicates open competition, is for a kit identification, now strip A2 qualification detector mobile/mobile laboratory test. Performance will occur in...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on September 17, 2025, for COVID-19 diagnostic test kits under contract 4569502136. The order, valued at $3,600.00 with a fixed-price contract type that includes economic price adjustment provisions, is scheduled for completion by September 26, 2025. The products will be delivered to Lockhart, Florida, and the award was made by the Defense Logistics Agency Medical Supply Chain without a...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D626F22V7Delivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order valued at $2,400 for COVID-19 test kits by the Defense Logistics Agency Medical Supply Chain. The contract was awarded on December 15, 2025, with an ultimate completion date of December 24, 2025, and will be performed in Lake Mary, Florida. This delivery order utilizes a fixed-price with economic price adjustment pricing structure and was awarded on a full and open competitive basis without set-aside designation. This delivery order represents a continuation of Abbott Rapid DX's established role as a critical supplier of diagnostic testing products to federal healthcare agencies. The company specializes in point-of-care testing devices and rapid antigen tests, with particular expertise in COVID-19 diagnostic solutions. Abbott Rapid DX maintains an extensive portfolio of indefinite delivery vehicle contracts across multiple Veterans Integrated Service Networks and the Defense Health Agency, enabling efficient procurement of diagnostic testing supplies on an as-needed basis to support federal healthcare operations and medical readiness programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 12/14/25 |